Navigating PV Divergence: Compliance Tips for New Entrants
July 8th 2021With small biotechs facing similar expectations as large pharma in drug safety and pharmacovigilance, despite less resources, identifying the key differences between US and EU requirements can help these companies craft a practical path to multi-region compliance.
Building Belonging: Pharma’s New Focus in DE&I
July 8th 2021Along with the industry’s massive effort to tackle the health and social problems exposed by COVID, pharma companies have spent the last year addressing the internal impact of racial inequalities following the murder of George Floyd.